Metolazone Tablets

Type of Posting: 
Revision Bulletin
Posting Date: 
27–Jan–2012
Official Date: 
01–Feb–2012
Expert Committee: 
Monographs—Small Molecules 2
Reason for Revision: 
Compliance

In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 2 Expert Committee has revised Metolazone Tablets monograph. The purpose for the revision is to add Dissolution Test 1 and Dissolution Test 2 for FDA approved products.  

The Metolazone Tablets Revision Bulletin supersedes the currently official Metolazone Tablets monograph.  The Revision Bulletin will be incorporated in Second Supplement to USP 35–NF 30.

Should you have any questions, please contact Sujatha Ramakrishna, Ph.D, M.B.A. (301–816–8349, sxr@usp.org.) or Hui-Zhi (Hillary) Cai, Ph.D. (301-230-3379, hzc@usp.org).